Page 385 - Binder2

• Ensuring pre-infusion safety protocols like
antihistamine premedication or blood pressure
checks.
• Managing immediate reactions—from mild
flushing to full-blown anaphylaxis.
• Documenting and justifying every dose for
insurance reimbursement.

This system makes physicians managers of risk—
navigators of complexity—not always healers in the
holistic sense. Their clinical energy is often consumed not
by patient insight, but by orchestration.

But edible biologics, particularly those formulated for
mucosal tolerance and immune retraining, upend that
framework. They eliminate the infusion chair, reduce
procedural requirements, and minimize acute immune
complications. Suddenly, the doctor's value shifts—not
because it decreases, but because it evolves.

The Rise of the Therapeutic Strategist

Without the procedural burden, the physician’s role
becomes more longitudinal, more analytical, and more
relational. They’re no longer managing a series of acute
touchpoints. Instead, they’re shaping a multi-year strategy
of immune modulation.

In this new model, the physician:

• Monitors disease progression with immune literacy.
They don't just track symptom flares—they read deeper
into cytokine patterns, mucosal integrity, tolerance
markers, and microbiome shifts. They understand how

383